Rankings
▼
Calendar
APGE Q1 2022 Earnings — Apogee Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
APGE
Apogee Therapeutics, Inc.
$4B
Q1 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$4M
Net Income
-$4M
EPS (Diluted)
$-0.09
Cash Flow
Operating Cash Flow
$0
Free Cash Flow
$0
Stock-Based Comp.
$0
← FY 2022
All Quarters
Q2 2022 →